Scarica l'app Stockscreener
0.8311
34.68%
0.214
Dopo l'orario di chiusura:
.82
-0.0111
-1.34%
Plus Therapeutics Inc Borsa (PSTV) Ultime notizie
Plus Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:PSTV - Benzinga
H.C. Wainwright Maintains Plus Therapeutics(PSTV.US) With Buy Rating, Maintains Target Price $3 - 富途牛牛
Why Cidara Therapeutics Was Such a Healthy Stock Today - AOL.com
Maxim Group Maintains Plus Therapeutics(PSTV.US) With Buy Rating, Maintains Target Price $3 - 富途牛牛
Buy Rating for Plus Therapeutics Driven by Strategic Advancements and Market Expansion for CNSide Test - TipRanks
Plus Therapeutics (PSTV) Stock Rallies as UnitedHealthcare Approves Cancer Test Coverage - parameter.io
Why CytomX Therapeutics Stock Was Skyrocketing This Week - AOL.com
Plus Therapeutics (PSTV) Soars 40% as Firm Seals Partnership with United Healthcare - MSN
PSTV ERUPTS: UnitedHealthcare Backs Plus Therapeutics’ CNS Cancer Test—Stock Pops, Analysts Cheer, and the Real Winners Could Be Patients - ts2.tech
Massive Gains: 10 Stocks Investors Can’t Stop Buying - Insider Monkey
These 3 Penny Stocks are Soaring Today: PLUS, EVAX, DVLT - AOL.com
Plus Therapeutics Shares Surge After UnitedHealthcare Coverage Deal - MSN
Buy Rating for Plus Therapeutics Driven by CNSide Coverage and Promising Pipeline Developments - TipRanks
Plus Therapeutics (PSTV) Rockets 40% on Major Insurance Win for Cancer Detection Tool – Here's Why Traders Are Buzzing - RagingBull
Plus Therapeutics Pops on UNH Pact - Baystreet.ca
Plus Therapeutics (PSTX) Surges After Securing UnitedHealthcare Coverage for CNSide Test - GuruFocus
Plus Therapeutics stock soars after UnitedHealthcare agreement By Investing.com - Investing.com Nigeria
Plus Therapeutics stock soars after UnitedHealthcare agreement - Investing.com
PSTV: D. Boral Capital Maintains 'Buy' Rating with $5 PT | PSTV Stock News - GuruFocus
Plus Therapeutics rises on the back of UnitedHealthcare coverage deal - Seeking Alpha
D. Boral Capital Maintains Plus Therapeutics (PSTV) Buy Recommendation - Nasdaq
Plus Therapeutics announces national coverage agreement with UnitedHealthcare - TipRanks
Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare Insurance Company for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer - The Manila Times
Plus Therapeutics Announces National Coverage Agreement - GlobeNewswire
Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare For CNS Cancer Diagnostic Kit - Yahoo Finance
51 Million Americans Gain Access: Plus Therapeutics' 92% Accurate Cancer Test Wins Major Insurance Deal - Stock Titan
Plus Therapeutics receives $1.9 million payment from cancer research fund By Investing.com - Investing.com Nigeria
Plus Therapeutics Announces Additional $1.9 Million Advance Payment from CPRIT - GlobeNewswire
Plus Therapeutics receives $1.9 million payment from cancer research fund - Investing.com India
Plus Therapeutics receives $1.9M CPRIT payment for cancer program - MSN
Plus Therapeutics (PSTV) Analyst Rating Maintained at 'Buy' by D. Boral Capital | PSTV Stock News - GuruFocus
Plus Therapeutics (PSTV) Secures Additional $1.9M Funding from C - GuruFocus
Plus Therapeutics announces $1.9M advance payment from CPRIT - TipRanks
Plus Therapeutics, Inc. Secures $1.9 Million Payment from CPRIT as Part of $17.6 Million Grant for Leptomeningeal Cancer Treatment Development - Quiver Quantitative
$17.6M Cancer Research Grant: Plus Therapeutics Receives Second Payment for CNS Cancer Treatment Trial - Stock Titan
Fund Flows: Is Plus Therapeutics Inc. stock showing strong momentumEarnings Miss & Community Consensus Stock Picks - خودرو بانک
Market Pulse: Is Plus Therapeutics Inc forming bullish engulfing patterns2025 EndofYear Setup & Fast Gain Stock Trading Tips - خودرو بانک
Winners Losers: Should you avoid Plus Therapeutics Inc stock right nowWeekly Trade Analysis & Real-Time Buy Zone Alerts - khodrobank.com
Analyst Downgrade: What dividend growth rate does Plus Therapeutics Inc offerJuly 2025 Macro Moves & Entry Point Confirmation Alerts - خودرو بانک
Technical Analysis: What dividend growth rate does Plus Therapeutics Inc offer2025 Support & Resistance & Stepwise Swing Trade Plans - خودرو بانک
Should you avoid Plus Therapeutics Inc. stock right nowJuly 2025 Big Picture & High Conviction Investment Ideas - khodrobank.com
Plus Therapeutics Announces Successful Accreditation and Certification for Its CNSide Diagnostics Clinical Laboratory - citybiz
Plus Therapeutics Announces Successful Accreditation and - GlobeNewswire
Breakout Watch: Can Plus Therapeutics Inc reach all time highs this yearMarket Risk Report & Community Verified Trade Alerts - خودرو بانک
Plus Therapeutics (PSTV) Rating Maintained as 'Buy' by D. Boral Capital | PSTV Stock News - GuruFocus
CNSide Diagnostics Achieves Key Accreditation Milestone for Hous - GuruFocus
Aug Wrap: What is the dividend yield of Plus Therapeutics IncMarket Trend Summary & Community Trade Idea Sharing Platform - khodrobank.com
Major Regulatory Milestone: Plus Therapeutics' CNSide Lab Gets Federal Approval for CNS Cancer Testing - Stock Titan
Aug Momentum: Will Plus Therapeutics Inc. benefit from sector rotation2025 Market Trends & Technical Pattern Based Signals - خودرو بانک
Returns Recap: What is Plus Therapeutics Inc.’s valuation compared to sectorQuarterly Performance Summary & Consistent Profit Trade Alerts - khodrobank.com
Levels Update: What is the long term forecast for Plus Therapeutics Inc. stockIPO Watch & Comprehensive Market Scan Insights - khodrobank.com
Plus Therapeutics drops 5%, files prospectus for 17M share secondary offering - MSN
Fund Flows: Is Plus Therapeutics Inc stock undervalued right nowExit Point & Low Volatility Stock Recommendations - خودرو بانک
Aug PostEarnings: What dividend growth rate does Plus Therapeutics Inc offerJuly 2025 Chart Watch & Detailed Earnings Play Alerts - خودرو بانک
Aug Mood: What is the dividend yield of Plus Therapeutics IncLong Setup & Fast Moving Trade Plans - khodrobank.com
Risk Recap: Can Plus Therapeutics Inc sustain its profitabilityQuarterly Trade Report & Smart Money Movement Tracker - khodrobank.com
Aug Macro: Is Oriental Culture Holding LTD a good ESG investmentMarket Performance Recap & High Return Trade Opportunity Guides - خودرو بانک
Institution Moves: Can Plus Therapeutics Inc stock double in the next year2025 Major Catalysts & Low Risk High Win Rate Stock Picks - khodrobank.com
Aug Big Picture: Is Plus Therapeutics Inc stock undervalued right now2025 Market Trends & Free Expert Verified Stock Movement Alerts - خودرو بانک
1.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):